(Q30352137)

15 October 2017

Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults (English)

1 reference

15 October 2017

1 reference

4

Tae Un Yang

1 reference

15 October 2017

9

Woo Joo Kim

1 reference

15 October 2017

2

Hee Jin Cheong

1 reference

15 October 2017

3

Ji Yun Noh

1 reference

15 October 2017

8

Won Suk Choi

1 reference

15 October 2017

Joon Young Song

1

1 reference

15 October 2017

Yu Bin Seo

series ordinal

5

1 reference

15 October 2017

Kyung-Wook Hong

series ordinal

6

1 reference

15 October 2017

In Seon Kim

series ordinal

7

1 reference

15 October 2017

3 July 2013

1 reference

Clinical and Experimental Vaccine Research

15 October 2017

1 reference

15 October 2017

2

1 reference

15 October 2017

2

1 reference

15 October 2017

115-119

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

15 October 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

A systematic review of intradermal influenza vaccines

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Immunogenicity and safety of intradermal influenza vaccination in healthy older adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Immunogenicity of hepatitis B vaccines: implications of immune memory

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Epidermal Langerhans cells: from neurons to nature's adjuvants

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Antibody responses after dose-sparing intradermal influenza vaccination.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710919

Dose sparing with intradermal injection of influenza vaccine

26 November 2018

1 reference

12 December 2020

Serum antibody responses after intradermal vaccination against influenza

1 reference

12 December 2020

Intradermal influenza vaccination--can less be more?

1 reference

12 December 2020

The immunogenicity of intradermal influenza vaccination in COPD patients

1 reference

12 December 2020

CDC recommendations expand vaccine indications

1 reference

12 December 2020

10.7774/CEVR.2013.2.2.115

Identifiers

DOI

1 reference

15 October 2017

1 reference

15 October 2017

1 reference